4//SEC Filing
EDWARDS MARK G 4
Accession 0001209191-19-039017
CIK 0001427925other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 6:58 PM ET
Size
7.4 KB
Accession
0001209191-19-039017
Insider Transaction Report
Form 4
EDWARDS MARK G
Director
Transactions
- Award
Stock Option (Right to Buy)
2019-06-25+7,500→ 7,500 totalExercise: $2.19From: 2019-07-25Exp: 2029-06-25→ Common Stock (7,500 underlying) - Award
Common Stock
2019-06-25+3,750→ 203,750 total
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The restricted stock units shall vest in two equal consecutive annual installments on June 25, 2020 and June 25, 2021, subject to Reporting Person's continuous service to the Company.
- [F3]The shares subject to the option vest as follows: 1/24th of the shares subject to the option vest in equal monthly installments over 24 months, subject to Reporting Person's continuous service to the Company.
Documents
Issuer
ACELRX PHARMACEUTICALS INC
CIK 0001427925
Entity typeother
Related Parties
1- filerCIK 0001190429
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 6:58 PM ET
- Size
- 7.4 KB